On March 22, 2022 Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announces that President and CEO Robert Hoffman will participate at the Maxim Group 2022 Virtual Growth Conference, which is being held on March 28-30, 2022 (Press release, Kintara Therapeutics, MAR 22, 2022, View Source [SID1234610588]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mr. Hoffman will present a corporate overview which will become available on Monday, March 28, 2022 at 9:00 a.m. ET.

Investors can view the presentation by registering for the conference here and also request a one-on-one meeting with management to be arranged following the conclusion of the conference.